We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Fort Worth's $6.7B Boom: How Sensible Policy Fuels Texas Growth
about 4 hours ago

AI Agent Crisis: New Book Offers Fix for 70% Failure Rate
about 9 hours ago

Chris Spurling: Build Confidence Through Daily Habits, Not Waiting
about 12 hours ago

Talia's Steakhouse Prepares for Passover 2026 with Kosher Seder Meals
about 13 hours ago

HR News
CommonOffice Named Top 5 HR/Payroll Software in Canada After 14 Years of Growth
3 days ago
IRS Alert: Avoid Costly Penalties with Proactive Payroll Record Reviews
4 days ago
HR.com Honors 2026 Talent Acquisition Award Winners for Recruitment Excellence
4 days ago
HR Leaders Unite to Shape Future of People Analytics with AI Insights
5 days ago
JDXpert Launches JDX+: AI-Powered Platform Solves Job Data Chaos
12 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
Fort Worth's $6.7B Boom: How Sensible Policy Fuels Texas Growth
about 4 hours ago
UGI Launches Easton Gas System Upgrades, Offers Conversion Opportunities
about 6 hours ago
Crypto News
ZeroStack Hits $840K in 0G Token Staking Rewards, Boosting AI Asset Strategy
3 days ago
NxGen Extends CAND Token Launch to Boost Liquidity Amid Market Volatility
3 days ago
Chainlink Co-Founder: Crypto's Future Lies Beyond Price Charts
3 days ago
Forward Industries Reports Q1 as Solana Treasury, Posts $585M Loss Amid Staking Gains
3 days ago
SOLOWIN Holdings Secures $100M Deal to Boost Fintech Expansion
4 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
Heart Association's Special Issue Redefines Women's Cardiovascular Care
about 2 hours ago
Dr. Reddy's Desert Mobile Medical Revolutionizes Healthcare with In-Home Concierge Services
about 10 hours ago
Technology News
FleetCollect Launches IFTA Automation App to Replace Paper Logs for Truckers
about 13 hours ago
Cybersecurity Leader Offers Business-Enabling Security Transformation Approach
about 13 hours ago
GVT Migrates FAMCare to Microsoft Azure for Enhanced Performance & Security
about 13 hours ago
Marco Bell Photo Expands Design-Focused Architectural Photography Across South Florida
about 18 hours ago
MelGeek Launches Horus Gaming Mouse: Art Meets Esports Performance
1 day ago
Events & Conferences
Evil Comedy's Monday Nights: Where Santa Rosa Finds Laughter & Community
2 days ago
Alpine's Mayor Eaves Details Thoughtful Growth in West Texas Hub
2 days ago
Accu-Temp's $9K AC Giveaway Honors First Responders & Teachers
2 days ago
LIXTE Advances Cancer Therapy LB-100 While Sponsoring Health Equity Summit
3 days ago
45Drives to Showcase Next-Gen Ceph Performance at Raleigh 2026 Event
4 days ago







